Oxurion Receives Transparency Notification from Atlas Special Opportunities LLC

Oxurion NV, a biopharmaceutical firm in Leuven, Belgium, has reported receiving a transparency notification. The notification, dated December 30, 2024, was issued by Atlas Special Opportunities LLC. Atlas informed Oxurion that it held 35,039 shares out of a total of 2,567,406 outstanding shares. This disclosure places Atlas below the 3% threshold following the sale of voting securities.

This event is in compliance with Belgian transparency legislation, specifically Article 14 of the Law of May 2, 2007, concerning the disclosure of major holdings. Further details about the changes in holdings can be accessed in the provided annex.